Magnetar Financial LLC
Institutional investor · Portfolio as of Q3 2022
Top Holdings1,356 positions
CHANGE HEALTHCARE INC | 4.1M | $113.1M | 1.6% | — | — | 14 qtrssince 2019-Q2 | Decreased 0 |
CHURCHILL CAPITAL CORP VII | 11.1M | $108.7M | 1.5% | — | — | 3 qtrssince 2022-Q1 | Increased 76 |
LHC GROUP INC | 647,493 | $106M | 1.5% | — | — | 3 qtrssince 2022-Q1 | Decreased 0 |
Boston Scientific Corp | 2.5M | $98M | 1.4% | $40.08 | -3.38% | 13 qtrssince 2019-Q3 | Decreased 0 |
Txnm Energy Inc | 2M | $90M | 1.2% | $40.56 | -1.12% | 8 qtrssince 2020-Q4 | Decreased 0 |
VMWARE INC-CLASS A | 834,750 | $88.9M | 1.2% | — | — | 2 qtrssince 2022-Q2 | Decreased 0 |
BLACK KNIGHT INC | 1.4M | $87.6M | 1.2% | — | — | 3 qtrssince 2022-Q1 | Decreased 0 |
IROBOT CORP | 1.5M | $84M | 1.2% | $56.93 | 0.00% | 1 qtr | New 68 |
DUKE REALTY CORP | 1.7M | $83M | 1.2% | — | — | 2 qtrssince 2022-Q2 | Decreased 0 |
SIGNIFY HEALTH INC | 2.8M | $80.7M | 1.1% | — | — | 2 qtrssince 2022-Q2 | Increased 76 |
SPIRIT AIRLS INC | 4.2M | $80M | 1.1% | — | — | 3 qtrssince 2022-Q1 | Increased 76 |
SHAW COMMUNICATIONS INC-B | 3.1M | $76.4M | 1.1% | — | — | 7 qtrssince 2021-Q1 | Decreased 0 |
MERIDIAN BIOSCIENCE INC | 2.2M | $70.9M | 1.0% | $7.15 | 0.00% | 1 qtr | New 58 |
YAMANA GOLD INC | 15.4M | $69.7M | 1.0% | — | — | 2 qtrssince 2022-Q2 | Decreased 0 |
First Horizon Corporation Com | 3M | $68.1M | 0.9% | $20.14 | -1.22% | 3 qtrssince 2022-Q1 | Decreased 0 |
1Life Healthcare Inc | 4M | $67.8M | 0.9% | — | — | 1 qtr | New 58 |
Merck & Co Inc | 771,489 | $66.4M | 0.9% | $72.93 | +4.89% | 4 qtrssince 2021-Q4 | Increased 58 |
KKR ACQUISITION HOLDING I CO | 6.6M | $65.3M | 0.9% | — | — | 5 qtrssince 2021-Q3 | Increased 67 |
ACTIVISION BLIZZARD INC | 850,567 | $63.2M | 0.9% | — | — | 3 qtrssince 2022-Q1 | Decreased 0 |
COWEN INC - A | 1.6M | $63M | 0.9% | — | — | 1 qtr | New 58 |
Magnetar Financial LLC manages $7.2B across 1356 positions as of Q3 2022. Top holdings: CHNG (1.6%), CVII (1.5%), LHCG (1.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 3/5.0.
Active quarter - 461 new positions, 767 exits, 547 increased. Top move: CVII (INCREASED, conviction 76). Portfolio: $7.2B across 1356 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR